Dr Erik Wambre

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Dave Bloom - 2018/05/29

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

Dave Bloom - 2018/01/30

What they discover could guide the design of a new strategy for immune intervention.

Th2A: the Key to Unlocking Better Testing and a Cure for...

Dave Bloom - 2017/08/11

A look at what all the excitement is about.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: Dr Erik Wambre

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

Th2A: the Key to Unlocking Better Testing and a Cure for...